Rhode Island HB 7039: AN ACT RELATING TO BUSINESSES AND PROFESSIONS - PHARMACEUTICAL COST TRANSPARENCY (Directs the state board of pharmacy to annually identify up to fifteen prescription drugs with increased costs and provide the list to the attorney general to obtain reasons for the cost increases.)

Status: 01/28/2020 Committee recommended measure be held for further study (as of 2020-01-28)

State: Rhode Island · Session: 2020 · Bill: HB 7039

Subjects: Business & Professions, Fees, Prescription drugs, State Departments

Sponsors: Hull, Lombardi, Walsh

View Rhode Island HB 7039 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.